Early Detection

Your chances of surviving melanoma is determined by how deep it has gone, using a measurement called the Breslow Thickness. The average depth at which MoleMap identifies melanoma is 0.6mm, which gives nearly 100% chance of survival in 5 years. The average of other skin check providers reduces your chances of survival to 90%*. Are you willing to take the risk?

More Accurate

Because MoleMap can more accurately identify what is and what isn’t melanoma, there’s far less need to surgically remove benign (harmless) moles. With MoleMap, the ratio of benign moles removed to find one melanoma is 4:1. Elsewhere twenty moles are removed to find one melanoma.


Our treatment recommendations are completely impartial. And at the end of the day, we would far rather you avoid unnecessary surgeries, saving you money and scarring.

The Original MoleMap

The term molemap was first coined by ‘MoleMap by Dermatologists’ back in 1997. It then became a commonly used industry term before MoleMap were able to trademark it. So when you get your skin checked for melanoma, make sure you that you’re not simply getting a molemap from a GP or a skin clinic. Be sure you’re getting the very best melanoma detection service available from MoleMap by Dermatologists.

World Renowned

MoleMap’s data is so respected, it is used for studies and educational programs at a number of world leading cancer centres including the Mayo clinic in the USA and MSKCC (Memorial Sloane-Kettering Cancer Clinic). A MoleMap published study (The “Ugly Duckling” Sign) found that identifying pigmented moles that look different from a person’s other moles – the “ugly duckling” sign – is a practical way to spot malignant skin cancer. This study made headlines around the world.


  • MoleMap Internal Audit. Benign to malignant ratio from a sample of 700 recommended excisions from 2010-2013. Sensitivity from documentation of reported missed melanomas.
  • Youl, P. H et al. Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary care skin cancer clinic doctors? Med J Aust 2007;187(4):215-220.
  • Scope A, et al. The “Ugly Duckling” Sign. Arch Dermatol. 2008;144(1):58-64.
  • * http://www.aihw.gov.au/cancer/melanoma/